Back to BNP Paribas Asset Management Holding S.A. BNP Paribas Asset Management Holding S.A.

XENEXENE
Showing 8 of 10 quarters

Position history for BNP Paribas Asset Management Holding S.A.BNP Paribas Asset Management Holding S.A.'s holdings in XENON PHARMACEUTICALS INC

BNP Paribas Asset Management Holding S.A. holds 1.3M shares of XENE (XENON PHARMACEUTICALS INC), worth $77.9M as of 2026-Q2. The position was decreased (-3.8% shares). XENE represents 0.1% of BNP Paribas Asset Management Holding S.A.'s portfolio.

Current Value

$77.9M

Current Shares

1.3M

Total Value Change

+$60.6M

Total Shares Change

+851,657

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.3M
-3.8%
$77.9M0.1%$60.36
0
2026-Q1
Increased
1.3M
+26.6%
$78M0.1%$43.79
37
2025-Q4
Increased
1.1M
+58.2%
$47.5M0.1%$44.12
42
2025-Q3
Increased
670,257
+1.4%
$26.9M0.1%$39.06
29
2025-Q2
Decreased
661,082
-6.1%
$20.7M0.1%$32.40
0
2025-Q1
Increased
703,795
+6.0%
$23.6M0.1%$34.26
30
2024-Q4
Increased
663,704
+51.2%
$26M0.1%$38.53
40
2024-Q3
Increased
439,074
+4.3%
$17.3M0.0%$38.65
29

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used